Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - Drugs.com MedNews
Links shared publicly online about this topic.
- 240total visits
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - Drugs.com MedNews
View full resource at drugs.com
Tags: Cancer, Breast Cancer, Drug, Women's Health
Most Recently Shared on June 6, 2011 at 1:32 am By:
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - http://bit.ly/j8vbsn
Breast Cancer Research: Dr. Feldman Explains New Study on Exemestane | Columbia University Department of Surgery Blog
columbiasurgery.net — “As reported in the NYT, the drug exemestane was found to reduce breast cancer occurance in post-menopausal women at high risk of developing breast cancer.” View full resource at columbiasurgery.net
Most Recently Shared on October 20, 2011 at 5:15 pm By:
What is exemestane? How is it used to prevent the?occurrence?of breast cancer in high risk women? http://t.co/S6ydEMcQ
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women
health.yahoo.net — “SATURDAY, June 4 (HealthDay News) -- The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found.” View full resource at health.yahoo.net
Most Recently Shared on June 6, 2011 at 4:27 am By:
Jane Anderson Healthy Eating Advisor
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women http://bit.ly/lRQuoZ
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women
health.yahoo.net — “SATURDAY, June 4 (HealthDay News) -- The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found.” View full resource at health.yahoo.net
Most Recently Shared on June 5, 2011 at 6:42 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women: SATURDAY, June 4 (HealthDay News) -- The anti-estro... http://bit.ly/mqZ2sM
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - MSN Health - Breast Cancer
health.msn.com — “But at least one cancer expert says more research is needed” View full resource at health.msn.com
Most Recently Shared on June 4, 2011 at 9:25 pm By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women http://ow.ly/1d3lGD
Aromasin (exemestane) Reduces Breast Cancer Risk In Postmenopausal Women, Study - QualityPoint Technologies
qualitypointtech.net — “Exemestane (Aromasin), an aromatase inhibitor, was found to lower invasive breast cancer rates by 65% in moderate and high-risk postmenopausal females, researchers at the Massachusetts General Hospital Cancer Center in Boston reported. An aromatase inhibitor inhibits aromatase, an enzyme involved in the production of estrogen estradiol. Many breast cancers are promoted by estrogens. After the menopause, most estrogen comes from the action of aromatase. Aromatase inhibitors can be very effective ” View full resource at qualitypointtech.net
Most Recently Shared on June 4, 2011 at 8:45 pm By:
Aromasin (exemestane) Reduces Breast Cancer Risk In Postmenopausal Women, Study: Exemestane (Aromasin), an aromata... http://bit.ly/k4JrWI
Aromasin cuts risk of breast cancer in some groups | Reuters
reuters.com — “CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.A” View full resource at reuters.com
Most Recently Shared on June 4, 2011 at 7:30 pm By:
Hisham Rana, MD Doctor and Physician
News: Aromasin cuts risk of breast #cancer in some groups http://reut.rs/iT7pgK - #health
Aromasin cuts risk of breast cancer in some groups
health.yahoo.net — “The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.” View full resource at health.yahoo.net
Most Recently Shared on June 4, 2011 at 7:22 pm By:
Jane Anderson Healthy Eating Advisor
Aromasin cuts risk of breast cancer in some groups http://bit.ly/lEEXsV
Aromasin cuts risk of breast cancer in some groups
health.yahoo.net — “The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.” View full resource at health.yahoo.net
Most Recently Shared on June 4, 2011 at 7:20 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Aromasin cuts risk of breast cancer in some groups: The estrogen-blocker Aromasin was found to reduce the risk o... http://bit.ly/iBtOzx
Aromasin cuts risk of breast cancer in some groups | Reuters
reuters.com — “CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.A” View full resource at reuters.com
Most Recently Shared on June 4, 2011 at 4:11 pm By:
HealthIT Policy Health News and Health IT
Aromasin cuts risk of breast cancer in some groups: CHICAGO (Reuters) - Pfizer Inc's breast cancer drug Aromasin... http://bit.ly/myJ50z
Aromasin cuts risk of breast cancer in some groups | Reuters
reuters.com — “CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.A” View full resource at reuters.com
Most Recently Shared on June 4, 2011 at 3:56 pm By:
Aromasin cuts risk of breast cancer in some groups http://reut.rs/mL5Q0w
Aromasin cuts risk of breast cancer in some groups | Reuters
reuters.com — “CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.A” View full resource at reuters.com
Most Recently Shared on June 4, 2011 at 3:53 pm By:
Aromasin cuts risk of breast cancer in some groups: CHICAGO (Reuters) - Pfizer Inc's breast cancer drug Aromasin... http://bit.ly/jW0nw2
Switching Early Breast Cancer Patients To Exemestane Improves Long-term Survival, Study Finds
feeds.sciencedaily.com — “New research has found that switching post-menopausal women with early breast cancer to the drug exemestane (Aromasin) after two or three years of tamoxifen rather than keeping them on tamoxifen for five years improves the chance of remaining cancer free and reduces the risk of death for at least the next six years.” View full resource at feeds.sciencedaily.com
Most Recently Shared on September 23, 2009 at 6:12 pm By:
Switching Early Breast Cancer Patients To Exemestane Improves Long-term Survival, Study Finds: New research has .. http://bit.ly/8xuOB
Switching early breast cancer patients to exemestane improves long-term survival
physorg.com — “New research has found that switching post-menopausal women with early breast cancer to the drug exemestane (Aromasin) after two or three years of tamoxifen rather than keeping them on tamoxifen for five years improves the chance of remaining cancer free and reduces the risk of death for at least the ...” View full resource at physorg.com
Most Recently Shared on September 22, 2009 at 12:07 am By:
Switching early breast cancer patients to exemestane improves long-term survival http://bit.ly/3ZSdcL
Advertisement
